THE DIAGNOSTIC USE OF AMOBARBITAL SODIUM ("AMYTAL SODIUM") IN BRAIN DISEASE

Edwin A. Weinstein · Robert L. Kahn · Leroy A. Sugarman · Louis Linn

51 citations0/0 files storedAmerican Journal of Psychiatry

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Psychological Testing and Assessment Psychosomatic Disorders and Their Treatments Neurology and Historical Studies

Abstract

The use of amobarbital sodium (amytal sodium R) as a diagnostic test for brain disease is described. In 57 of 88 patients with proven brain disease, who on clinical examination showed no disturbances in behavior, the intravenous administration of the drug produced patterns of disorientation for time, place, and person and denial of illness. These changes were not obtained in any of 50 control patients. The applicability of the procedure to the study of alterations in brain function caused by structural, iatrogenic, metabolic, and toxic agents is discussed.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 51 citations exist upstream.

Cited by

1954SERIAL ADMINISTRATION OF THE "AMYTAL TEST" FOR BRAIN DISEASE 1954CHANGES IN SYMBOLIC EXPRESSION WITH AMYTAL SODIUM 1982Identifying organic brain disease by amobarbital sodium interview: Diagnostic pitfalls

Imported from OpenAlex (CC0) — nothing here is generated.